18 Nov 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses to the current economic climate, inflation, and government and central bank reactions.
30 Sep 2020 - Mainstream Group Holdings Limited (ASX:MAI) CEO Martin Smith provides an update on the company's FY20 results, the impact of COVID-19, strategy and outlook.
30 Sep 2020 - Nuheara Limited (ASX:NUH) Managing Director & CEO Justin Miller provides an update on the company's range of innovative audio wearables, changes in its marketing and distribution as a result of COVID19, financial position and outlook.
29 Sep 2020 - Elixinol Global Limited (ASX:EXL) CEO Oliver Horn provides an updates on trading conditions across the company's key markets, its new distribution agreement in the UK with the Well Pharmacy Group, and early success with its CBD (cannabidiol ) skincare range.
28 Sep 2020 - Respiri Limited (ASX:RSH) CEO Marjan Mikel discusses clinical results from the company's innovative asthma management tool wheezo, a combination eHealth app and handheld device, as well as the company's strategy and outlook.
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
23 Sep 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses signs of market recovery, government support, coronavirus vaccines and small cap performance.
23 Sep 2020 - Clayton Utz Partner Brendan Bateman discusses climate change risks, the legal duties of directors and how to factor such risks into financial valuations.
21 Sep 2020 - Clayton Utz Partner Brendan Bateman discusses climate change risks, the legal duties of directors and how to factor such risks into financial valuations.
09 Sep 2020 - BrainChip Holdings Limited (ASX:BRN) President & CEO Louis DiNardo provides an update on collaboration and partnerships for the company's AI chip, Akida.
